Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs. Penumbra sells its products to hospitals and clinics primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra P logo is a trademark of Penumbra, Inc.

NYSE: PEN 148.20 -2.60 -1.72%
Volume: 2,874,361
Pricing delayed 20 minutes June 22, 2018 04:02 PM

SEC Filings

Date Filing Type Filing Description Download
Date June 19, 2018 Filing Type Form 4 Filing Description Statement of Changes in Beneficial Ownership Download
Date May 31, 2018 Filing Type Form SD Filing Description Specialized Disclosure Report Download

IR Contact


Penumbra, Inc. Headquarters One Penumbra Place
Alameda, CA 94502